Skip to main content

ESTUDIO IN VITRO Y EN EL MODELO DE ENDOCARDITIS EXPERIMENTAL DE LA EFICACIA DE NUEVAS COMBINACIONES ORALES Y PARENTERALES DE ANTIBIOTICOS PARA EL TRATAMIENTO DOMICILIARIO DE LA ENDOCARDITIS INFECCIOSA.

PI20/00830

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
Execution centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-faecalis and Non-faecium Enterococcal Isolates With/Without VanC Phenotype, Clinical Implications for Infective Endocarditis

  • García-González, Javier
  • Cañas, María Alexandra|||0000-0002-0521-7204
  • Cuervo, Guillermo|||0000-0002-7075-943X
  • Hernández Meneses, Marta|||0000-0001-9991-1127
  • Verdejo, Miguel Ángel|||0000-0001-7870-0515
  • Bodro, Marta|||0000-0002-0520-8279
  • Díez de los Ríos, Javier
  • Gasch, Oriol|||0000-0001-8518-458X
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Falces, Carles|||0000-0002-3483-3786
  • Perissinotti, Andrés|||0000-0003-4190-2425
  • Vidal, Bárbara
  • Quintana, Eduard|||0000-0002-5386-7463
  • Moreno Camacho, Asunción|||0000-0001-6382-0039
  • Piquet, Maria
  • Roca, Ignasi|||0000-0002-1800-1576
  • Fernandez-Pittol, Mariana|||0000-0002-1685-7127
  • San José-Villar, Sol M.
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Miró, José M.|||0000-0001-8057-7755
(1) Background: Alternative antibiotics are needed to treat infective endocarditis (IE) caused by non-faecalis/non-faecium enterococci; we aimed to assess the in vitro activity of ampicillin plus ceftriaxone (AMP + CTR) against these enterococci and to describe its clinical efficacy in IE cases. (2) Methods: Time-kill curves with standard (ISI) and high (IHI) inocula were performed to test VanC isolates [3 E. casseliflavus (ECAS) and 1 E. gallinarum (EGALL)] and non-VanC isolates [1 E. durans (EDUR), 1 E. hirae (EHIR) and 1 E. raffinosus (ERAF)]. The narrative literature review of IE cases treated with AMP + CTR was analyzed alongside three study cases. Clinical outcomes were relapse and death. (3) Results: Ampicillin plus gentamicin (AMP + GEN) showed synergistic and bactericidal activity against most isolates. AMP + CTR was synergistic at ISI for EGALL, EDUR, and EHIR and bactericidal against EHIR. At IHI, indifferent activity was observed for all isolates. In IE cases treated with AMP + CTR, it was only effective for EDUR and EHIR. Clinical information for EGALL IE is lacking. For IE caused by ECAS and ERAF, AMP + CTR seems suboptimal or ineffective, respectively. (4) AMP + CTR cannot be recommended for treating IE due to ECAS/ERAF. In contrast, this combination was effective in IE caused by EDUR/EHIR and could be recommended.